Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
    25.
    发明授权
    Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators 失效
    含有四环衍生物的杂原子作为选择性雌激素受体调节剂

    公开(公告)号:US07329654B2

    公开(公告)日:2008-02-12

    申请号:US10307735

    申请日:2002-12-02

    CPC分类号: C07D493/04

    摘要: The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and processes for their preparation. The compounds of the invention are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosis; hormone sensitive cancers and hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids, osteoarthritis and as contraceptive agents, alone or in combination with a progestogen or progestogen antagonist.

    摘要翻译: 本发明涉及新颖的含杂原子的四环衍生物,含有它们的药物组合物,它们在治疗和/或预防由一种或多种雌激素受体介导的障碍及其制备方法中的用途。 本发明的化合物可用于治疗和/或预防与雌激素消耗相关的疾病,例如潮热,阴道干燥,骨质减少和骨质疏松症; 激素敏感性癌症和乳腺,子宫内膜,子宫颈和前列腺增生; 子宫内膜异位症,子宫肌瘤,骨关节炎和避孕药,单独或与孕激素或孕激素拮抗剂联合使用。